A Targeted AAV Gene Therapy Product Candidate, 4D-310, for the Treatment of Fabry Disease: Intravenous Biodistribution, Transgene Expression & Safety in Non-Human PrimatesMarch 13, 2023/in Scientific Presentation/by Erik Allison /wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison /wp-content/uploads/4dmt_logo.svg Erik Allison2023-03-13 16:59:092023-03-13 17:03:13A Targeted AAV Gene Therapy Product Candidate, 4D-310, for the Treatment of Fabry Disease: Intravenous Biodistribution, Transgene Expression & Safety in Non-Human Primates